Phenazopyridine Hydrochloride
- Product NDC
- 68071-5339
- 11-digit product format
- 680715339
- Labeler code
- 68071
- Product ID
- 68071-5339_5dd1e57a-558e-3c68-e063-6394a90ab963
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Phenazopyridine Hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals, Inc.
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start
- 2023-10-19
- Substance
- PHENAZOPYRIDINE HYDROCHLORIDE
- Active strength
- 200 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Phenazopyridine Hydrochloride
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| PHENAZOPYRIDINE HYDROCHLORIDE | 200 mg/1 |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 68071-5339-6 | 68071533906 | 6 TABLET in 1 BOTTLE (68071-5339-6) | 6 tablet | 2026-10-14 | No | No | Current |